JP Morgan Chase
COCP icon

JP Morgan Chase’s Cocrystal Pharma COCP Stock Holding History

JP Morgan Chase’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-104
Closed -$148 – 7157
2025
Q1 		$148 Sell
104
-155
-60% -$289 ﹤0.01% 6834
2024
Q4 		$523 Sell
259
-152
-37% -$304 ﹤0.01% 6796
2024
Q3 		$723 Sell
411
-17
-4% -$33 ﹤0.01% 6759
2024
Q2 		$997 Sell
428
-115
-21% -$224 ﹤0.01% 6620
2024
Q1 		$776 Sell
543
-1,653
-75% -$2.58K ﹤0.01% 6668
2023
Q4 		$3.73K Buy
2,196
+452
+26% +$804 ﹤0.01% 6612
2023
Q3 		$3.26K Buy
1,744
+1,291
+285% +$3.24K ﹤0.01% 6455
2023
Q2 		$1.08K Buy
453
+202
+80% +$491 ﹤0.01% 6446
2023
Q1 		$0 Sell
251
-9
-3% -$20 ﹤0.01% 6754
2022
Q4 		$1K Sell
260
-73
-22% -$187 ﹤0.01% 6384
2022
Q3 		$1K Sell
333
-356
-52% -$1.67K ﹤0.01% 6305
2022
Q2 		$3K Sell
689
-166
-19% -$884 ﹤0.01% 6239
2022
Q1 		$6K Sell
855
-4,142
-83% -$27.5K ﹤0.01% 6283
2021
Q4 		$39K Buy
4,997
+4,902
+5,160% +$50.2K ﹤0.01% 6026
2021
Q3 		$1K Buy
+95
New +$1.26K ﹤0.01% 6377
2021
Q2 		– Sell
-117
Closed -$2K – 6374
2021
Q1 		$2K Buy
+117
New +$2.38K ﹤0.01% 5933

Other funds holding COCP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase's COCP Position: Q2 2025 in Review

JP Morgan Chase sold out of Cocrystal Pharma (COCP) in Q2 2025, closing a stake of 104 shares — an estimated $148 sold.

JP Morgan Chase first reported a position in COCP in Q1 2021 and held it in 16 quarters. The position peaked at $39K in Q4 2021. 22 funds tracked by Wall St. Rank hold COCP as of Q2 2025.

  • JP Morgan Chase reported no remaining Cocrystal Pharma position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 104 Cocrystal Pharma shares in Q2 2025, an estimated $148.
  • JP Morgan Chase first reported a position in Cocrystal Pharma in Q1 2021 and held it in 16 quarters.
  • JP Morgan Chase's Cocrystal Pharma position peaked at $39K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.